Recent News

• 11.09.2026 - Comment on CORONADO BIOSCIENCES IN-LICENSES IV TRAMADOL, A PHASE III READY ASSET, FROM REVOGENEX IRELAND LTD. by batpkrgamedownload
• 11.09.2026 - Comment on Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol by 0kzzapp
• 11.09.2026 - Comment on CORONADO BIOSCIENCES IN-LICENSES IV TRAMADOL, A PHASE III READY ASSET, FROM REVOGENEX IRELAND LTD. by ph777ny
• 11.09.2026 - Comment on Press Release Title 4 by x88dlcom
• 11.09.2026 - Comment on Press Release Title 3 by 09tr88
• 11.08.2026 - Comment on CORONADO BIOSCIENCES IN-LICENSES IV TRAMADOL, A PHASE III READY ASSET, FROM REVOGENEX IRELAND LTD. by phearnphp
• 11.08.2026 - Comment on Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol by vn789beat
• 11.08.2026 - Comment on Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol by xx88casino
• 11.08.2026 - Comment on Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol by phmi777
• 11.08.2026 - Comment on Press Release Title 3 by bet2888game

Recent Filings

• 11.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 03.30.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.23.2026 - 8-K Current report
• 02.23.2026 - EX-99.1 EX-99.1
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.06.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.31.2025 - 8-K Current report